← Insider buys
PCRX

Pacira BioSciences, Inc. · Healthcare

CEO and Chair David M Stack sold $1.6M of Pacira BioSciences, Inc.

Sold$1,561,998
$60.56Price
25,793Shares
−8%Stake

What PCRX did after the filing

Filed Jun 8, copier in the same day
The stock from Wed, Jun 8 close, $59.39
−7.1%
S&P 500, same days
−3.5%

Measured over 30 trading days, to the Jul 22 close.

Traded Mon, Jun 6. Filed Wed, Jun 8, 3:51 PM ET, during the session. Returns use the Jun 8 close and the Jul 22 close. Not investment advice.